1. Home
  2. VVR vs MRVI Comparison

VVR vs MRVI Comparison

Compare VVR & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invesco Senior Income Trust (DE)

VVR

Invesco Senior Income Trust (DE)

HOLD

Current Price

$3.32

Market Cap

509.5M

Sector

Finance

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.05

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVR
MRVI
Founded
1998
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
509.5M
472.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
VVR
MRVI
Price
$3.32
$3.05
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$4.57
AVG Volume (30 Days)
692.2K
1.1M
Earning Date
01-01-0001
02-25-2026
Dividend Yield
11.38%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$192,435,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.55
$1.67
52 Week High
$4.38
$4.40

Technical Indicators

Market Signals
Indicator
VVR
MRVI
Relative Strength Index (RSI) 57.31 32.07
Support Level $3.29 $3.06
Resistance Level $3.31 $3.21
Average True Range (ATR) 0.02 0.17
MACD 0.00 -0.05
Stochastic Oscillator 90.00 0.00

Price Performance

Historical Comparison
VVR
MRVI

About VVR Invesco Senior Income Trust (DE)

Invesco Senior Income Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide a high level of current income, consistent with the preservation of capital. The company invests in a portfolio of interests in floating or variable senior loans to corporations, partnerships, and other entities which operate in a variety of industries and geographic regions.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: